$1.35T
Total marketcap
$159.62B
Total volume
42.11%
BTC dominance

Pfizer Inc. PFE Price

49.82 USD {{ price }} -0.200317% {{change_pct}}%
Exchange
NYSE
Market Cap
277.42B USD
LOW - HIGH [24H]
49.27 - 50.34 USD
VOLUME [24H]
22.31M USD
{{ volume }}
P/E Ratio
14.11
Earnings per share
3.5 USD

Pfizer Inc. Price Chart

Pfizer Inc. PFE Financial and Trading Overview

Previous Close 50.39 USD
Open 50.38 USD
Bid 49.78 USD x 1100
Ask 49.82 USD x 1400
Day's Range 49.68 - 50.79 USD
52 Week Range 38.48 - 61.71 USD
Volume 22.42M USD
Avg. Volume 28.41M USD
Market Cap 280.19B USD
Beta (5Y Monthly) 0.623376
PE Ratio (TTM) 14.258783
EPS (TTM) 3.5 USD
Forward Dividend & Yield 1.6 (2.93%)
Ex-Dividend Date January 27, 2022
1y Target Est N/A

PFE Valuation Measures

Enterprise Value 316.52B USD
Trailing P/E 14.258783
Forward P/E 1.009913
PEG Ratio (5 yr expected) 0.01
Price/Sales (ttm) 4.041053
Price/Book (mrq) 3.7005188
Enterprise Value/Revenue 4.565
Enterprise Value/EBITDA 11.592

Trading Information

Pfizer Inc. Stock Price History

Beta (5Y Monthly) 0.623376
52-Week Change N/A
S&P500 52-Week Change N/A
52 Week High 61.71 USD
52 Week Low 38.48 USD
50-Day Moving Average 51.05 USD
200-Day Moving Average 49.65 USD

PFE Share Statistics

Avg. Volume (3 month) 28.41M USD
Avg. Daily Volume (10-Days) 28.47M USD
Shares Outstanding 5.61B
Float 5.61B
Short Ratio 1.5
% Held by Insiders 0.037%
% Held by Institutions 67.43%
Shares Short 66.01M
Short % of Float 1.17%
Short % of Shares Outstanding 1.17%

Dividends & Splits

Trailing Annual Dividend Rate 1.55
Trailing Annual Dividend Yield 3.07%
5 Year Average Dividend Yield 367.00%
Payout Ratio 0.45060003
Last Split Factor 1054:1000

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2020
Most Recent Quarter (mrq) October 3, 2021
Next Fiscal Year End December 31, 2022

Profitability

Profit Margin 28.68%
Operating Margin (ttm) 32.13%
Gross Margin 65.41%
EBITDA Margin 39.38%

Management Effectiveness

Return on Assets (ttm) 7.77%
Return on Equity (ttm) 27.74%

Income Statement

Revenue (ttm) 69.34B USD
Revenue Per Share (ttm) 12.41 USD
Quarterly Revenue Growth (yoy) 134.40%
Gross Profit (ttm) 33.33B USD
EBITDA 27.31B USD
Net Income Avi to Common (ttm) 19.57B USD
Diluted EPS (ttm) 3.501
Quarterly Earnings Growth (yoy) 454.50%

Balance Sheet

Total Cash (mrq) 29.7B USD
Total Cash Per Share (mrq) 5.29 USD
Total Debt (mrq) 39.88B USD
Total Debt/Equity (mrq) 52.5 USD
Current Ratio (mrq) 1.385
Book Value Per Share (mrq) 13.49

Cash Flow Statement

Operating Cash Flow (ttm) 32.29B USD
Levered Free Cash Flow (ttm) 42.43B USD

Profile of Pfizer Inc.

Country United States
State NY
City New York
Address 235 East 42nd Street
ZIP 10017
Phone 212 733 2323
Website https://www.pfizer.com
Industry Drug Manufacturers—General
Sector(s) Healthcare
Full Time Employees 78500

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and pain under the Eliquis, Chantix/Champix, and Premarin family brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zithromax, Vfend, and Panzyga brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Prevnar 13/Prevenar 13 (pediatric/adult), Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Pfizer-BioNTech COVID-19 vaccine brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, and Eucrisa/Staquis brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; Arvinas, Inc.; and Syapse, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Q&A For Pfizer Inc. Stock

What is a current PFE stock price?

Pfizer Inc. PFE stock price today per share is 49.82 USD.

How to purchase Pfizer Inc. stock?

You can buy PFE shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Pfizer Inc.?

The stock symbol or ticker of Pfizer Inc. is PFE.

Which industry does the Pfizer Inc. company belong to?

The Pfizer Inc. industry is Drug Manufacturers—General.

How many shares does Pfizer Inc. have in circulation?

The max supply of Pfizer Inc. shares is 5.57B.

What is Pfizer Inc. Price to Earnings Ratio (PE Ratio)?

Pfizer Inc. PE Ratio is 14.11739500 now.

What was Pfizer Inc. earnings per share over the trailing 12 months (TTM)?

Pfizer Inc. EPS is 3.5 USD over the trailing 12 months.

Which sector does the Pfizer Inc. company belong to?

The Pfizer Inc. sector is Healthcare.